| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 2/6 |
| Past Performance | 1/6 |
| Financial Health | 3/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
+ 1 more risk
Viatris Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$10.55 |
| 52 Week High | US$12.57 |
| 52 Week Low | US$8.10 |
| Beta | 1.15 |
| 1 Month Change | -4.10% |
| 3 Month Change | -2.81% |
| 1 Year Change | 26.18% |
| 3 Year Change | -4.14% |
| 5 Year Change | n/a |
| Change since IPO | -27.28% |
Recent News & Updates
Recent updates
Shareholder Returns
| VIA | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | 0.6% | -3.1% | -2.0% |
| 1Y | 26.2% | -31.9% | -0.3% |
Return vs Industry: VIA exceeded the German Pharmaceuticals industry which returned -31.9% over the past year.
Return vs Market: VIA exceeded the German Market which returned -0.3% over the past year.
Price Volatility
| VIA volatility | |
|---|---|
| VIA Average Weekly Movement | 4.4% |
| Pharmaceuticals Industry Average Movement | 7.0% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: VIA has not had significant price volatility in the past 3 months.
Volatility Over Time: VIA's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1961 | 38,000 | Scott Smith | www.viatris.com |
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs).
Viatris Inc. Fundamentals Summary
| VIA fundamental statistics | |
|---|---|
| Market cap | €12.54b |
| Earnings (TTM) | €51.33m |
| Revenue (TTM) | €14.48b |
244.2x
P/E Ratio0.9x
P/S RatioIs VIA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| VIA income statement (TTM) | |
|---|---|
| Revenue | US$15.43b |
| Cost of Revenue | US$8.69b |
| Gross Profit | US$6.73b |
| Other Expenses | US$6.68b |
| Earnings | US$54.70m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 09, 2024
| Earnings per share (EPS) | 0.046 |
| Gross Margin | 43.64% |
| Net Profit Margin | 0.35% |
| Debt/Equity Ratio | 88.5% |
How did VIA perform over the long term?
See historical performance and comparison